Health TrialsbyHealthPanel

Barriers/Facilitators and Care Coordination of Native Hawaiians & Kidney Disease

ConditionKidney Disease, Chronic
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Hawaii

About this trial

Native Hawaiians (NH) are 9.5 times more likely to be on dialysis or need a kidney transplant compared to Whites. They have the highest end-stage kidney disease (ESKD) incidence rates in the nation, begin dialysis at younger ages (30-50 years), and one of the most under-studied racial/ethnic groups in chronic kidney disease (CKD) research. This project's outcome is to improve kidney disease follow-up among early stage NHs at high risk by aligning health equity with a culturally appropriate care coordination systems model.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

greater or equal to 18 years

self-reported as Native Hawaiian

eGFR less than 60 ml/min/1.73m2 (Stage 3a-3b CKD) and/or greater or equal to 30 mg/g UACR

have participated in the NKFH KEDS Program within 3 months

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • culturally informed care coordination intervention

    Behavioral

    Culturally Informed Care Coordination Strategies

  • No Intervention - Usual Care Group

    Other intervention

    No Intervention - Usual Care Group

Treatment groups

120 Participants
are divided into 2 treatment groups
Group A: Culturally Informed Care CoordinationExperimental treatment 2 interventions
Group B: Usual Care GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Acceptability to Intervention

Acceptability (the degree to which an intervention is perceived a good fit) Acceptability will be measured by a survey likert scale of 1 (not acceptable) - 10 (most acceptable) Name of measurement tool is reference in Procter et al (p. 69): Procter E, Silmere H, Raghavan R, et al. Outcomes for implementation research, conceptual distinctions, measurement challenges, and research agenda. Adm Policy Mental Health. 2022: 38 (2): 65-76.

Time frame
9 months
2

Adoption of the Intervention

Adoption (intent to implement) Adoption will be scored as 0 (not at all implemented), 5 (somewhat implemented), and 10 (fully implemented). Name of measurement tool is reference in Procter et al (p. 69): Procter E, Silmere H, Raghavan R, et al. Outcomes for implementation research, conceptual distinctions, measurement challenges, and research agenda. Adm Policy Mental Health. 2022: 38 (2): 65-76.

Time frame
9 months
3

Feasibility of the Intervention

Feasibility (possibility of successful implementation), Feasibility will be measured by a survey likert scale of 1 (not feasible) - 10 (most feasible). Name of measurement tool is reference in Procter et al (p. 69): Procter E, Silmere H, Raghavan R, et al. Outcomes for implementation research, conceptual distinctions, measurement challenges, and research agenda. Adm Policy Mental Health. 2022: 38 (2): 65-76.

Time frame
9 months

Secondary outcomes

1

Beliefs to Change of the Intervention

TOTAL SCORE of 4 Questions will measure the secondary outcome measure - Beliefs to Change. Believe that rescreening for eGFR \& UACR can directly influence your health Believe that integrating eGFR and UACR are worthwhile use of health care services Believe that primary care providers are committed to supporting rescreening for eGFR \& UACR Believe that rescreening for eGFR and UACR belong in primary care health services. Asked to complete a survey with a 10-point Likert scale (0=Strongly Disagree to 10=Strongly Agree). Scores will be added to obtain a Total Score to measure the secondary outcome measure - Beliefs to Change.

Time frame
9 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Hawaii

Lead sponsor

National Kidney Foundation, United States

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: